Five ways JTM can improve your early phase clinical trial supply chain
Increasing overheads linked to high value biologics and personalised medicines, highly variable patient enrolment and the constant need to reduce timelines and capacity for waste caused by expensive, time sensitive drugs and limited availability can combine to create a perfect storm for sponsors of early phase clinical trials.
Explore five of the key ways JTM can improve your early phase clinical supply chain:
- Ease the forecasting headache
- Reduce waste of expensive IMP
- Increase control over expiry date assignment
- To improve patient centricity
- To expedite key study milestones
Download our latest guide to discover why Just in Time Manufacturing (JTM) has the potential to add significant value to early phase trials, through its ability to respond quickly to shifting demand, while preserving drug product.View Resource
Almac Clinical Services
Guided by our extensive clinical supply experience and expertise, Almac Clinical Services is recognised as an innovative, global solution provider within the specialised and complex market of clinical trial supply.
Our integrated and adaptable solutions offer the most flexible approach to support the delivery of global clinical trials from protocol right through to patient delivery.
Our core purpose is to be the partner of choice, to deliver the next generation of health care solutions effectively and to focus on winning for you and your patients.